A Study of Paliperidone Palmitate in Japanese Patients With Schizophrenia
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the long-term safety and tolerability of
paliperidone palmitate in Japanese patients with schizophrenia. Secondary objectives of this
study are to: explore the efficacy on symptoms of schizophrenia and the maintenance of
treatment effect; explore the pharmacokinetics of paliperidone palmitate through sparse
pharmacokinetic sampling.